Summit Therapeutics
Senior Director, Oncology Clinical Educators
Remote-Field (US) · Director
Stay score
odds of building a lasting career here
Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.
Lottery odds assume a STEM candidate.
Personalize to your clock →Employer immigration record
from this employer's Department of Labor filings
Files H-1B transfers
Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.
Community outcomes
No reports yet — be the first to help the next applicant.
About the role
- The role is not a sales or marketing role, its educational objectives, performance measures, and incentives will remain independent of sales and marketing performance.
Responsibilities
- Recruit, develop, coach, and retain Clinical Educators, and build a high-performing, clinically credible team, fostering clinical excellence, accountability, collaboration, and continuous professional development.
- Ensure the team maintains current knowledge of oncology disease states, approved product information, clinical developments, and the evolving treatment landscape through ongoing training and professional development.
Nice to have
- Summit's core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people.
- Summit's team is inspired to touch and help change lives through Summit's clinical studies in the field of oncology.
- Summit has multiple global Phase 3 clinical studies, including:
- Non-small Cell Lung Cancer (NSCLC)
- Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC.
- Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC.
- Colorectal Cancer (CRC)
- Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy.
Compensation
- Establish and lead the Oncology Clinical Educator function, defining the vision, strategy, operating model, and annual priorities to support launch readiness and evolving business needs.
Benefits
- This leader will oversee the delivery of compliant, on-label education to healthcare professionals to support clinical readiness and appropriate treatment implementation.
- Provide strategic leadership and oversight of field execution, ensuring consistent, high-quality educational engagement and responsiveness to evolving healthcare professional needs.
- Lead the identification and assessment of educational gaps, clinical practice needs, treatment workflows, and patient management considerations to inform educational strategies and resources.
- Establish and maintain appropriate relationships with professional nursing organizations, oncology association, and other relevant external stakeholders to identify educational needs and opportunities for collaboration
- Build and maintain the infrastructure, processes, systems, and governance necessary to support a scalable and effective Clinical Education function.
- Serve as a strategic advisor to senior leadership, communicating field educational insights, emerging needs, operational challenges, and opportunities to strengthen the clinical education capabilities.
- Develop and execute a national clinical education strategy, including territory design, resource allocation, account prioritization, and educational engagement plans across academic and community oncology settings.
Company info
- Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence.
This listing is sourced directly from Summit Therapeutics's careers page and normalized into a canonical job model.